suPAR as a Prognostic Marker of Ugandan Children at Risk of Severe and Fatal Malaria.
suPAR as a Prognostic Marker of Ugandan Children at Risk of Severe and Fatal Malaria.
08 Jun 2022
Current malaria diagnostic tests do not reliably identify children at risk of severe and fatal infection. Host immune and endothelial activation contribute to malaria pathogenesis. Soluble urokinase-type plasminogen activator receptor (suPAR) is a marker of these pathways. We hypothesized that measuring suPAR at presentation could risk-stratify children with malaria.